stockrowUnited Therapeutics Corporation
UTHR Healthcare Drug Manufacturers Specialty & Generic
United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024.
- Revenue
- +4.13%
- EPS
- −21.7%
- Free cash flow
- −63.7%
Quarter to September 2026, against a year earlier
Follow UTHR
Alert me
United Therapeutics Corporation (UTHR) Book value per share
United Therapeutics Corporation's book value per share at the end of fiscal 2025 was 160×, up 12.4% from 143× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 147×. Over the past ten years it has ranged from 34.5× (fiscal 2015) to 160× (fiscal 2025) — the current reading is the highest in ten years. United Therapeutics Corporation ranks 2nd of 84 Drug Manufacturers Specialty & Generic companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 160× | 12.36% |
| FY2024 | 143× | 11.48% |
| FY2023 | 128× | 21.30% |
| FY2022 | 105× | 19.56% |
| FY2021 | 88.2× | 14.78% |
| FY2020 | 76.8× | 21.01% |
| FY2019 | 63.5× | (0.98%) |
| FY2018 | 64.1× | 34.20% |
| FY2017 | 47.8× | 13.02% |
| FY2016 | 42.3× | 22.39% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 147× | (2.17%) |
| Jun 2026 | 150× | 10.75% |
| Mar 2026 | 136× | (15.31%) |
| Dec 2025 | 160× | 6.46% |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| UTHR United Therapeutics Corporation | 147× |
| NBIX Neurocrine Biosciences, Inc. compare | 38.2× |
| ELAN Elanco Animal Health Incorporated compare | 13.2× |
| ZTS Zoetis Inc. compare | 7.5× |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 6.8× |
| RDY Dr. Reddy's Laboratories Ltd compare | 4.9× |
| TAK Takeda Pharmaceutical Co. compare | 0.0× |
| HLN Haleon PLC Sponsored ADR compare | 0.0× |
| VTRS Viatris Inc. compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on UTHR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement